Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Outcomes of patients (pts) with advanced urothelial carcinoma (aUC) treated with immune checkpoint inhibitors (ICIs): Associations with age, race, sex and smoking history.
Outcomes of patients (pts) with advanced urothelial carcinoma (aUC) treated with immune checkpoint inhibitors (ICIs): Associations with age, race, sex and smoking history. Makrakis, D., Talukder, R., Carril, L., de Kouchkovsky, I., Park, J. J., Bilen, M., McKay, R. R., Agarwal, N., Zakharia, Y., Devitt, M. E., Pinato, D., Hoimes, C. J., Gartrell, B., Tripathi, A., Bamias, A., Drakaki, A., Murgic, J., Di Lorenzo, G., Grivas, P., Khaki, A. LIPPINCOTT WILLIAMS & WILKINS. 2021View details for DOI 10.1200/JCO.2021.39.15_suppl.e16526
View details for Web of Science ID 000708120302226